Cipla boosts investment in GoApptiv with Rs. 42 crore infusion, raising its stake to 22.99%. This marks their third investment in the digital tech company, aligning with Cipla s aim to expand healthcare accessibility. GoApptiv, led by ex-pharma executives, uses a digital platform to deliver quality medicines to underserved regions. This move, praised by Cipla s CEO Umang Vohra, emphasizes tech-enabled healthcare for growth and enhanced patient solutions.